Vantage Investment Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $29.6M | Buy |
|
|||||
|
2025
Q2 | $31.3M | Sell |
|
|||||
|
2025
Q1 | $31.9M | Sell |
|
|||||
|
2024
Q4 | $49.9M | Buy |
|
|||||
|
2024
Q3 | $51.1M | Sell |
|
|||||
|
2024
Q2 | $76.3M | Sell |
|
|||||
|
2024
Q1 | $77M | Buy |
|
|||||
|
2023
Q4 | $50M | Buy |
|
|||||
|
2023
Q3 | $28M | Sell |
|
|||||
|
2023
Q2 | $26.1M | Buy |
|
|||||
|
2023
Q1 | $24.4M | Sell |
|
|||||
|
2022
Q4 | $24.9M | Sell |
|
|||||
|
2022
Q3 | $19.9M | Sell |
|
|||||
|
2022
Q2 | $54.5M | Hold |
|
|||||
|
2022
Q1 | $54.3M | Buy |
|